Qiagen N.V. (NYSE:QGEN) Q4 2023 Earnings Conference Call February 7, 2024 9:00 AM ET
Company Participants
John Gilardi - VP, Corporate Communications & IR
Thierry Bernard - Chief Executive Officer
Roland Sackers - Chief Financial Officer
Conference Call Participants
Derik De Bruin - Bank of America
Odysseas Manesiotis - Berenberg
Casey Woodring - JPMorgan
Aisyah Noor - Morgan Stanley
Douglas Schenkel - Wolfe Research
Falko Friedrichs - Deutsche Bank
Matthew Sykes - Goldman Sachs
Operator
Good day. I'm Melinda, your PGI call operator. Welcome, and thank you for joining Qiagen's Fourth Quarter 2023 Earnings Conference Call Webcast. [Operator Instructions] Please be advised that this call is being recorded at QIAGEN's request and will be made available on their Internet site. The prepared remarks will be followed by a question-and-answer session. [Operator Instructions]
At this time, I'd like to introduce your host, John Gilardi, Vice President, Head of Corporate Communications and Investor Relations at QIAGEN. Please go ahead.
John Gilardi
Thank you, operator, and a welcome to all of you today who are joining us for this call. We appreciate your interest in QIAGEN. Our speakers are Thierry Bernard, our Chief Executive Officer, and Roland Sackers, our Chief Financial Officer. We also have Phoebe Loh from the IR team with us. This call is being webcast live and will be archived on the investors section of our website at www.qiagen.com. You can also find a copy of the quarterly results press release and presentation on our website. We will begin with some remarks from Thierry and Roland, followed by a Q&A session.
Before we start, let me note that we are going to have an Analyst and Investor Day on Monday, June 17 in New York. An invitation to the event will be going out in the next few weeks, but please mark this in your calendars. And also before we start, let’s briefly go over our safe harbor statement.
The views expressed during this conference call and the responses to your questions represent the perspectives of management as of today, February 7, 2024. We will be making statements and providing responses to your questions that convey our intentions, beliefs, expectations or
predictions for the future.
These forward-looking statements fall under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. They involve risks and uncertainties, and actual results may differ materially from those suggested by these forward-looking statements. Factors that could influence results are mentioned in our filings with the U.S. Securities and Exchange Commission. These filings are available on the SEC’s website and also on our website. QIAGEN disclaims any intention or obligation to update any forward-looking statements.